Valuation : AngioDynamics, Inc.

Market Cap 639M 550M 516M 472M 882M 60.44B 889M 6.11B 2.38B 30.89B 2.4B 2.35B 99.48B P/E 2027 *
-29.4x
P/E 2028 * -52.7x
Enterprise Value 639M 550M 516M 472M 882M 60.44B 889M 6.11B 2.38B 30.89B 2.4B 2.35B 99.48B EV / Sales 2027 *
1.9x
EV / Sales 2028 * 1.8x
Free-Float
86.06%
Yield 2027 *
-
Yield 2028 * -
1 day-0.96%
1 week-1.96%
Current month-4.09%
1 month+1.98%
3 months+38.12%
6 months+40.13%
Current year+20.48%
1 week 15.16
Extreme 15.16
16.29
1 month 14.83
Extreme 14.83
16.29
Current year 9.39
Extreme 9.39
16.29
1 year 9.39
Extreme 9.39
16.29
3 years 5.26
Extreme 5.26
16.29
5 years 5.26
Extreme 5.26
32
10 years 5.26
Extreme 5.26
32
Manager TitleAgeSince
Chief Executive Officer 62 31/03/2016
Director of Finance/CFO 51 22/10/2019
Chief Tech/Sci/R&D Officer - 31/12/2016
Director TitleAgeSince
Chairman 65 28/04/2014
Director/Board Member 67 28/01/2007
Director/Board Member 62 31/03/2016
Date Insider Type Main position Quantity % Market Cap. Importance
30/07/26 Sell

General Counsel

-23,370 0.0565%
22/07/26 Exercice

Executive/Senior Manager

40,889 0.0990%
22/07/26 Exercice

General Counsel

27,417 0.0664%
Change 5-day change 1-year change 3-year change Capi.($)
-0.96%-1.96%+45.67%+100.13% 639M
-1.52%-2.51%-17.70%+5.78% 188B
+1.00%+3.48%+0.92%+13.36% 119B
+0.26%+4.98%+14.26%+92.74% 64.35B
-1.31%-1.09%+22.44%+46.84% 52.59B
+0.05%-0.27%-1.05%-32.62% 51.11B
+0.02%+0.47%+13.67%-11.96% 33.85B
+0.80%+5.60% - - 32.1B
+0.03%-0.97%+37.67%-15.93% 24.12B
-1.44%-4.21%-7.37%+11.97% 23.39B
Average -0.31%-0.12%+12.06%+23.37% 58.96B
Weighted average by Cap. -0.38%-0.57%+0.09%+16.14%

Financials

2027 *2028 *
Net sales 337M 290M 272M 249M 465M 31.89B 469M 3.22B 1.25B 16.3B 1.27B 1.24B 52.48B 355M 306M 287M 262M 490M 33.57B 494M 3.39B 1.32B 17.16B 1.33B 1.3B 55.26B
Net income -22.3M -19.19M -18.01M -16.47M -30.75M -2.11B -30.99M -213M -82.95M -1.08B -83.74M -81.91M -3.47B -12.67M -10.9M -10.23M -9.36M -17.46M -1.2B -17.6M -121M -47.12M -612M -47.57M -46.53M -1.97B
Net Debt - -
Logo AngioDynamics, Inc.
AngioDynamics, Inc. is a transformative medical technology company. The Company is focused on restoring healthy blood flow in the body's vascular system, expanding cancer treatment options and improving quality of life for patients. It designs, manufactures, and sells a range of medical, surgical and diagnostic devices used by professional healthcare providers for vascular access, for the treatment of peripheral vascular disease and for use in oncology and surgical settings. Its devices are generally used in minimally invasive, image-guided procedures. Its segments include Med Tech and Med Device. The Med Tech segment is comprised of its technology portfolio including Auryon, the thrombus management platform and NanoKnife. The Med Device segment includes its Core, Venous, Ports and other Oncology products. Its product types are Ablation, Catheters, Medical Balloons, and Ports. The Catheter products include Angiographic Catheters, Uni-Fuse Infusion Catheter and Drainage Catheters.
Employees
632
Date Price Change Volume
03/09/26 US$15.47 -0.96% 438,279
02/09/26 US$15.62 -1.51% 311,414
01/09/26 US$15.86 -1.67% 237,937
31/08/26 US$16.13 +1.77% 358,532
28/08/26 US$15.85 +0.44% 200,738
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
BB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
15.47USD
Average target price
20.00USD
Spread / Average Target
+29.28%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. ANGO Stock